{"id":"https://openalex.org/W2001782289","doi":"https://doi.org/10.1097/yic.0000000000000018","title":"Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder","display_name":"Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-20","ids":{"openalex":"https://openalex.org/W2001782289","doi":"https://doi.org/10.1097/yic.0000000000000018","mag":"2001782289","pmid":"https://pubmed.ncbi.nlm.nih.gov/24257717","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3979887"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0000000000000018","doi":"https://doi.org/10.1097/yic.0000000000000018","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000018","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2001782289"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/yic.0000000000000018","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106185345","display_name":"Jean\u2010Philippe Boulenger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Philippe Boulenger","raw_affiliation_strings":["aUniversity Department of Adult Psychiatry, CHU de Montpellier, Montpellier, France bH. Lundbeck A/S, Copenhagen, Denmark","University Department of Adult Psychiatry, CHU de Montpellier, Montpellier, France","e-mail: [email\u00a0protected]","fax: +33 4673 39660","to Jean-Philippe Boulenger, MD, University Department of Adult Psychiatry, H\u00f4pital La Colombiere, CHRU de Montpellier, 39 Avenue Charles Flahault, F-34295 Montpellier Cedex 5, France Tel: +33 4673 39753"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aUniversity Department of Adult Psychiatry, CHU de Montpellier, Montpellier, France bH. Lundbeck A/S, Copenhagen, Denmark","institution_ids":["https://openalex.org/I4210093292"]},{"raw_affiliation_string":"University Department of Adult Psychiatry, CHU de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +33 4673 39660","institution_ids":[]},{"raw_affiliation_string":"to Jean-Philippe Boulenger, MD, University Department of Adult Psychiatry, H\u00f4pital La Colombiere, CHRU de Montpellier, 39 Avenue Charles Flahault, F-34295 Montpellier Cedex 5, France Tel: +33 4673 39753","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050375558","display_name":"Henrik Loft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Henrik Loft","raw_affiliation_strings":["H. Lundbeck A/S, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109243701","display_name":"Christina Kurre Olsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Christina Kurre Olsen","raw_affiliation_strings":["H. Lundbeck A/S, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Copenhagen, Denmark","institution_ids":["https://openalex.org/I133593841"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5106185345"],"corresponding_institution_ids":["https://openalex.org/I4210093292"],"apc_list":null,"apc_paid":null,"fwci":13.3063,"has_fulltext":true,"cited_by_count":202,"citation_normalized_percentile":{"value":0.99656229,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"29","issue":"3","first_page":"138","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9399999976158142},{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.765999972820282},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8949999809265137},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5730000138282776},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.8159999847412109},{"id":"https://openalex.org/keywords/recurrent-depressive-disorder","display_name":"recurrent depression","score":0.5},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5540000200271606},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5759999752044678},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9777822494506836},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8235775232315063},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.780075192451477},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.6383166909217834},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5966436266899109},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.593974769115448},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5446306467056274},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5265477299690247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.479148805141449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45367735624313354},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4515843987464905},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.4359470009803772},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3836013972759247},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3729426860809326},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3241207003593445},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27333056926727295},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.22203373908996582},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078784","descriptor_name":"Vortioxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D038622","descriptor_name":"Internationality","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/yic.0000000000000018","doi":"https://doi.org/10.1097/yic.0000000000000018","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000018","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3979887","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3979887/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3979887/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int Clin Psychopharmacol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:2962162","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3979887","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24257717","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24257717","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/yic.0000000000000018","doi":"https://doi.org/10.1097/yic.0000000000000018","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000018","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2001782289.pdf","grobid_xml":"https://content.openalex.org/works/W2001782289.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W143336295","https://openalex.org/W1539382539","https://openalex.org/W1570504112","https://openalex.org/W1924063373","https://openalex.org/W1987514922","https://openalex.org/W1987560991","https://openalex.org/W1988763037","https://openalex.org/W1993810702","https://openalex.org/W1994717858","https://openalex.org/W2003704397","https://openalex.org/W2004762037","https://openalex.org/W2011606125","https://openalex.org/W2022191212","https://openalex.org/W2036812642","https://openalex.org/W2048026164","https://openalex.org/W2051198709","https://openalex.org/W2054766240","https://openalex.org/W2056454671","https://openalex.org/W2059274457","https://openalex.org/W2061669920","https://openalex.org/W2061693930","https://openalex.org/W2063225659","https://openalex.org/W2066283885","https://openalex.org/W2084170778","https://openalex.org/W2085752173","https://openalex.org/W2089659183","https://openalex.org/W2108592835","https://openalex.org/W2131823335","https://openalex.org/W2146659162","https://openalex.org/W2160070901","https://openalex.org/W2164182651","https://openalex.org/W2574545871","https://openalex.org/W3090293687","https://openalex.org/W4254565755","https://openalex.org/W7046723572"],"related_works":["https://openalex.org/W2752826413","https://openalex.org/W845297282","https://openalex.org/W1986102787","https://openalex.org/W2054766240","https://openalex.org/W2303297560","https://openalex.org/W4386888577","https://openalex.org/W810408096","https://openalex.org/W1999690682","https://openalex.org/W2157621823","https://openalex.org/W2029732660"],"abstract_inverted_index":{"This":[0,19],"study":[1,23],"assessed":[2],"the":[3,128,183,242],"efficacy,":[4],"tolerability":[5],"and":[6,36,118,161,216,238],"safety":[7,226],"of":[8,150,244],"vortioxetine":[9,57,60,133,191],"versus":[10],"placebo":[11,146],"in":[12,76,104,224,241],"adults":[13],"with":[14,106,141,246],"recurrent":[15],"major":[16,247],"depressive":[17,248],"disorder.":[18,249],"double-blind,":[20],"randomized,":[21],"placebo-controlled":[22],"included":[24],"608":[25],"patients":[26,105,245],"[Montgomery-\u00c5sberg":[27],"Depression":[28],"Rating":[29,110],"Scale":[30,111,121],"(MADRS)":[31],"total":[32,78,102,122],"score":[33,42,79,103,123],"\u2265":[34,43,112,208],"26":[35],"Clinical":[37,94],"Global":[38,95],"Impression":[39,96],"-":[40,97],"Severity":[41],"4].":[44],"Patients":[45],"were":[46,135,193,210,222],"randomly":[47],"assigned":[48],"(1":[49],":":[50,52,54],"1":[51,53],"1)":[55],"to":[56,139,145,197],"15":[58,153],"mg/day,":[59,62],"20":[61,166],"duloxetine":[63],"60":[64],"mg/day":[65],"or":[66,231],"placebo.":[67,198],"The":[68],"primary":[69,129],"efficacy":[70,130],"endpoint":[71],"was":[72,201,236],"change":[73],"from":[74,179],"baseline":[75,107],"MADRS":[77,92,101,163],"at":[80,124],"week":[81,125],"8":[82],"(mixed":[83],"model":[84],"for":[85],"repeated":[86],"measurements).":[87],"Key":[88],"secondary":[89,188],"endpoints":[90],"were:":[91],"responders;":[93],"Improvement":[98],"scale":[99],"score;":[100],"Hamilton":[108],"Anxiety":[109],"20;":[113],"remission":[114],"(MADRS":[115],"\u2264":[116],"10);":[117],"Sheehan":[119],"Disability":[120],"8.":[126],"On":[127],"endpoint,":[131],"both":[132,190],"doses":[134,192],"statistically":[136,194],"significantly":[137,195],"superior":[138,196],"placebo,":[140,180],"a":[142],"mean":[143],"difference":[144],"(n":[147,175],"=":[148,159,172,176],"158)":[149],"-5.5":[151],"(vortioxetine":[152,165],"mg,":[154,167],"P":[155,168],"<":[156,169],"0.0001,":[157,170],"n":[158,171],"149)":[160],"-7.1":[162],"points":[164],"151).":[173],"Duloxetine":[174],"146)":[177],"separated":[178],"thus":[181],"validating":[182],"study.":[184],"In":[185],"all":[186],"key":[187],"analyses,":[189],"Vortioxetine":[199,235],"treatment":[200,243],"well":[202,239],"tolerated;":[203],"common":[204],"adverse":[205],"events":[206],"(incidence":[207],"5%)":[209],"nausea,":[211],"headache,":[212],"diarrhea,":[213],"dry":[214],"mouth":[215],"dizziness.":[217],"No":[218],"clinically":[219],"relevant":[220],"changes":[221],"seen":[223],"clinical":[225],"laboratory":[227],"values,":[228],"weight,":[229],"ECG":[230],"vital":[232],"signs":[233],"parameters.":[234],"efficacious":[237],"tolerated":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2001782289","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":29},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
